Clement Agoni Selected Research

vorasidenib

5/2021

Dual-Knockout of Mutant Isocitrate Dehydrogenase 1 and 2 Subtypes Towards Glioma Therapy: Structural Mechanistic Insights on the Role of Vorasidenib.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Clement Agoni Research Topics

Disease

7	Alzheimer Disease (Alzheimer's Disease) 09/2020 - 12/2018
5	Neoplasms (Cancer) 09/2022 - 10/2018
5	Tuberculosis (Tuberculoses) 04/2020 - 01/2018
3	Neurodegenerative Diseases (Neurodegenerative Disease) 03/2022 - 06/2019
3	COVID-19 01/2022 - 01/2021
3	Infections 02/2021 - 01/2018
2	Common Cold 02/2022 - 03/2020
2	Glioma (Gliomas) 10/2021 - 05/2021
1	Respiratory Tract Infections (Respiratory Tract Infection) 02/2022
1	Nervous System Diseases (Neurological Disorders) 11/2021
1	Human Influenza (Influenza) 02/2021
1	Cryptosporidiosis 01/2021
1	Extensively Drug-Resistant Tuberculosis 04/2020
1	Hypersensitivity (Allergy) 03/2020
1	Inflammation (Inflammations) 03/2020
1	Acute Lung Injury 03/2020
1	Brain Diseases (Brain Disorder) 01/2020
1	Immune System Diseases (Immune Disorders) 06/2019
1	Asthma (Bronchial Asthma) 01/2019
1	Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse) 01/2019
1	Disease Progression 01/2019
1	Allergic Rhinitis 01/2019
1	Glioblastoma (Glioblastoma Multiforme) 11/2018
1	Malaria 11/2018
1	Cardiovascular Diseases (Cardiovascular Disease) 01/2016
1	Sickle Cell Anemia (Hemoglobin S Disease) 01/2016

Drug/Important Bio-Agent (IBA)

7	Pharmaceutical PreparationsIBA 02/2022 - 01/2019
4	VaccinesIBA 01/2022 - 01/2021
3	Monoamine Oxidase (MAO)IBA 03/2022 - 11/2021
3	J147IBA 01/2020 - 06/2019
3	Mitochondrial Proton-Translocating ATPases (Mitochondrial ATP Synthase)IBA 01/2020 - 06/2019
3	Proteins (Proteins, Gene)FDA Link 06/2019 - 11/2018
2	TankyrasesIBA 09/2022 - 01/2019
2	Antiviral Agents (Antivirals)IBA 06/2021 - 02/2021
2	bedaquiline (R207910)IBA 04/2020 - 01/2019
2	LigandsIBA 04/2020 - 01/2018
2	LipidsIBA 03/2020 - 01/2016
2	Adenosine Triphosphate (ATP)IBA 09/2019 - 01/2019
2	Rifampin (Rifampicin)FDA LinkGeneric 01/2018 - 01/2018
1	ImidazolidinesIBA 09/2022
1	glycylpeptide N-tetradecanoyltransferaseIBA 02/2022
1	IMP-1088IBA 02/2022
1	Membrane Proteins (Integral Membrane Proteins)IBA 01/2022
1	Temozolomide (Temodar)FDA LinkGeneric 10/2021
1	Isocitrate Dehydrogenase (Isocitrate Dehydrogenase (NAD+))IBA 05/2021
1	vorasidenibIBA 05/2021
1	Neuraminidase (Sialidase)IBA 02/2021
1	Paromomycin (Paromomycin Sulfate)FDA LinkGeneric 01/2021
1	remdesivirIBA 01/2021
1	RNA-Dependent RNA Polymerase (RNA Dependent RNA Polymerase)IBA 01/2021
1	Caspase 6IBA 09/2020
1	2,4-diaminopyrimidineIBA 03/2020
1	ramatrobanIBA 03/2020
1	CRTH2 antagonist CT-133IBA 03/2020
1	benzothiopheneIBA 03/2020
1	SmokeIBA 03/2020
1	Prostaglandin D2IBA 03/2020
1	Formyl Peptide Receptors (Formyl Peptide Receptor)IBA 03/2020
1	Biological ProductsIBA 01/2020
1	KRN 7000 (KRN7000)IBA 01/2020
1	Galactosylceramides (Galactocerebrosides)IBA 01/2020
1	Folic Acid (Vitamin M)FDA LinkGeneric 01/2020
1	AntibodiesIBA 06/2019
1	fevipiprantIBA 01/2019
1	Protein Isoforms (Isoforms)IBA 01/2019
1	CaspasesIBA 01/2019
1	CAY 10471IBA 01/2019
1	Semaphorin-3AIBA 12/2018
1	naringeninIBA 12/2018
1	Tyrosine (L-Tyrosine)FDA Link 11/2018
1	Phosphoprotein Phosphatases (Phosphatases, Protein)IBA 11/2018
1	plasmepsin (plasmepsin I)IBA 11/2018
1	Heat-Shock Proteins (Heat-Shock Protein)IBA 10/2018
1	DNA-Directed RNA Polymerases (RNA Polymerase)IBA 01/2018
1	EnzymesIBA 01/2018
1	HDL CholesterolIBA 01/2016
1	CholesterolIBA 01/2016

Therapy/Procedure

15	Therapeutics 09/2022 - 01/2018
1	Drug Therapy (Chemotherapy) 10/2021
1	Self Medication 01/2021
1	Ligation 03/2020
1	Immunotherapy 01/2020